Bictegravir-Induced Drug Reaction With Eosinophilia and Systemic Symptoms in a Patient With Acute Human Immunodeficiency Virus.
DRESS
HIV
antiretroviral therapy
bictegravir
drug reaction with eosinophilia and systemic symptoms
Journal
Open forum infectious diseases
ISSN: 2328-8957
Titre abrégé: Open Forum Infect Dis
Pays: United States
ID NLM: 101637045
Informations de publication
Date de publication:
Mar 2023
Mar 2023
Historique:
received:
22
12
2022
accepted:
03
02
2023
entrez:
7
3
2023
pubmed:
8
3
2023
medline:
8
3
2023
Statut:
epublish
Résumé
Although drug reaction with eosinophilia and systemic symptoms (DRESS) is associated with antiretrovirals, there are no published reports of bictegravir-induced DRESS. Bictegravir is recommended as first-line treatment for patients with human immunodeficiency virus (HIV). Recognition of DRESS, its skin manifestations, and potential complications is vital for appropriate care and management of acute HIV.
Identifiants
pubmed: 36879628
doi: 10.1093/ofid/ofad066
pii: ofad066
pmc: PMC9985146
doi:
Types de publication
Journal Article
Langues
eng
Pagination
ofad066Informations de copyright
© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Déclaration de conflit d'intérêts
Potential conflicts of interest. MAD holds individual stocks in Abbvie, Abiomed Inc., Amgen Inc, Becton Dickinson, BioMarin Pharmaceutical Inc., Bristol-Myers Squibb, CVS Health Corporation, Gilead Sciences, Inc., Henry Schein, Inc., Hologic, Jazz Pharmaceuticals, Merck & Co., Inc., Quest Diagnostics, Vertex Pharmaceuticals, and West Pharmaceuticals. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
Références
Int J Gen Med. 2019 Oct 23;12:381-385
pubmed: 31695475
Contact Dermatitis. 2022 Jun;86(6):443-479
pubmed: 35233782
Br J Dermatol. 2013 Nov;169(5):1071-80
pubmed: 23855313
Infect Dis Ther. 2021 Sep;10(3):1331-1346
pubmed: 33977505
Allergol Int. 2019 Jul;68(3):301-308
pubmed: 31000444
Am J Med. 2011 Jul;124(7):588-97
pubmed: 21592453
Indian J Pharmacol. 2013 Jul-Aug;45(4):401-2
pubmed: 24014920
Indian J Sex Transm Dis AIDS. 2017 Jul-Dec;38(2):163-170
pubmed: 30148271
Br J Dermatol. 2016 Dec;175(6):1142-1144
pubmed: 27996122
Biomedicines. 2022 Apr 26;10(5):
pubmed: 35625735
J Am Acad Dermatol. 2019 Mar;80(3):670-678.e2
pubmed: 30240780